Glanbia Nutritionals has launched a new creatine monohydrate ingredient called CreaBev that the company says is more soluble and stable than other creatine monohydrate ingredients on the market.
Glanbia Nutritionals (Chicago, IL) has launched a new creatine monohydrate ingredient called CreaBev with a patent-pending encapsulation technology the company says makes it more soluble and stable than other creatine monohydrate ingredients on the market. In a short-term study conducted by the company, 98% of CreaBev’s creatine monohydrate remained present in water after two hours compared to standard creatine monohydrate, 11% of which degraded after only five minutes to the waste product creatinine.
In a long-term study, following exposure to the high processing temperatures of Ultra Heat Treatment (UHT), 70% of CreaBev’s creatine monohydrate remained after 12 months, while 95% of standard creatine monohydrate degraded after just three months. Additionally, CreaBev did not experience crystallization or clumping following UHT.
“Creatine has been a widely utilized ingredient for years and there is sufficient consumer knowledge on its benefits of use,” says Mayuresh Bedekar, senior product manager, Bioactives, for Glanbia, in a press release. “However, now manufacturers of pre- and post-workout products will have access to a more efficient form of creatine monohydrate that opens up new beverage product formulation possibilities.”